Ximiflam-MR Tablet is a combination medication containing Chlorzoxazone 250mg, Diclofenac 50mg, and Paracetamol 325mg, formulated to provide effective relief from musculoskeletal pain and inflammation. Chlorzoxazone acts as a centrally acting muscle relaxant, alleviating muscle spasms and discomfort. Diclofenac, a nonsteroidal anti-inflammatory drug (NSAID), exerts potent anti-inflammatory, analgesic, and antipyretic effects by inhibiting cyclooxygenase enzymes, thereby reducing the synthesis of prostaglandins responsible for pain and inflammation. Paracetamol complements these actions with its analgesic and antipyretic properties, enhancing overall pain control and fever reduction. This combination is particularly beneficial in conditions such as acute musculoskeletal injuries, strains, sprains, and other painful inflammatory disorders. Ximiflam-MR Tablet should be administered as directed by a healthcare professional, considering patient-specific factors including medical history and potential drug interactions. Caution is advised in patients with hepatic, renal, or gastrointestinal impairments. Common adverse effects may include gastrointestinal discomfort, dizziness, or allergic reactions; therefore, monitoring is recommended during therapy. This multi-ingredient formulation offers a synergistic approach to managing pain and inflammation, improving patient comfort and functional recovery.